SMA-话题@MedSci

#SMA#

157篇内容 | 3286人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1388955, encodeId=5b1313889555e, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Br J Cancer：转移性去势抵抗性前列腺癌中雄激素受体基因扩增状态与177Lu-PSMA-617治疗抗性相关, objectType=article, longId=215168, objectId=549b215168d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=549b215168d2, replyNumber=0, likeNumber=105, createdTime=2021-08-03, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=549b215168d2, moduleTitle=Br J Cancer：转移性去势抵抗性前列腺癌中雄激素受体基因扩增状态与177Lu-PSMA-617治疗抗性相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=549b215168d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388954, encodeId=f91113889540c, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=NEJM：177Lu-PSMA-617靶向放疗治疗PSMA阳性转移性去势抵抗性前列腺癌, objectType=article, longId=213197, objectId=2d2e21319ed9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d2e21319ed9, replyNumber=0, likeNumber=76, createdTime=2021-06-26, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d2e21319ed9, moduleTitle=NEJM：177Lu-PSMA-617靶向放疗治疗PSMA阳性转移性去势抵抗性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d2e21319ed9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388953, encodeId=e4581388953fd, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=BJU Int：PSMA PET和MRI预测中度和高度风险前列腺癌患者的早期结果, objectType=article, longId=212979, objectId=d6462129e904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6462129e904, replyNumber=0, likeNumber=70, createdTime=2021-06-22, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6462129e904, moduleTitle=BJU Int：PSMA PET和MRI预测中度和高度风险前列腺癌患者的早期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6462129e904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388952, encodeId=caad138895251, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=JAMA Neurol：Zolgensma治疗后5年，脊髓性肌肉萎缩症患者仍可获得长期临床缓解, objectType=article, longId=211985, objectId=93e021198556, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93e021198556, replyNumber=0, likeNumber=68, createdTime=2021-05-30, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93e021198556, moduleTitle=JAMA Neurol：Zolgensma治疗后5年，脊髓性肌肉萎缩症患者仍可获得长期临床缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93e021198556)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388951, encodeId=263013889519d, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Journal of Nuclear Medicine：美国单中心研究发现黑人前列腺癌68Ga-PSMA-11PET成像使用机会少, objectType=article, longId=211225, objectId=dfad211225a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfad211225a3, replyNumber=0, likeNumber=73, createdTime=2021-05-14, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfad211225a3, moduleTitle=Journal of Nuclear Medicine：美国单中心研究发现黑人前列腺癌68Ga-PSMA-11PET成像使用机会少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfad211225a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388950, encodeId=ace413889500b, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Cell Metab：肌酸通过激活Smad2/3促进肿瘤转移, objectType=article, longId=209473, objectId=cb362094e370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb362094e370, replyNumber=0, likeNumber=66, createdTime=2021-04-05, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb362094e370, moduleTitle=Cell Metab：肌酸通过激活Smad2/3促进肿瘤转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb362094e370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388949, encodeId=dd7a138894918, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Evrysdi治疗脊髓性肌萎缩症（SMA），CHMP持积极意见, objectType=article, longId=207698, objectId=b1e420e698d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1e420e698d6, replyNumber=0, likeNumber=75, createdTime=2021-03-01, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1e420e698d6, moduleTitle=Evrysdi治疗脊髓性肌萎缩症（SMA），CHMP持积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1e420e698d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388948, encodeId=33c21388948b9, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Acta Neuropathologica: 具有SMARCA4突变的非典型畸胎样/横纹肌样肿瘤在分子水平上不同于SMARCB1缺陷病例, objectType=article, longId=207267, objectId=b2cf20e26777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2cf20e26777, replyNumber=0, likeNumber=72, createdTime=2021-02-20, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2cf20e26777, moduleTitle=Acta Neuropathologica: 具有SMARCA4突变的非典型畸胎样/横纹肌样肿瘤在分子水平上不同于SMARCB1缺陷病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2cf20e26777)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388947, encodeId=e27c138894ef9, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=定价为天价的SMA疗法卖得还好吗, objectType=article, longId=207154, objectId=46d020e154a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46d020e154a6, replyNumber=0, likeNumber=94, createdTime=2021-02-17, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46d020e154a6, moduleTitle=定价为天价的SMA疗法卖得还好吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46d020e154a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388946, encodeId=2e66138894626, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Clin Cancer Res：PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性, objectType=article, longId=206884, objectId=a7cd206884c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7cd206884c6, replyNumber=0, likeNumber=73, createdTime=2021-02-08, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7cd206884c6, moduleTitle=Clin Cancer Res：PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7cd206884c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388945, encodeId=1dce1388945fa, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=ARTMS和Isotopia Molecular Imaging宣布成功通过QUANTM Irradiation System™和固态靶材，用经由回旋加速器生产的68Ga对PSMA-11进行多居里标记, objectType=article, longId=206000, objectId=9bbf2060009c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bbf2060009c, replyNumber=0, likeNumber=79, createdTime=2021-01-23, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bbf2060009c, moduleTitle=ARTMS和Isotopia Molecular Imaging宣布成功通过QUANTM Irradiation System™和固态靶材，用经由回旋加速器生产的68Ga对PSMA-11进行多居里标记, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bbf2060009c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388944, encodeId=2f451388944aa, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, objectType=article, longId=205740, objectId=214b205e4021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=214b205e4021, replyNumber=0, likeNumber=76, createdTime=2021-01-16, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=214b205e4021, moduleTitle=ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=214b205e4021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388943, encodeId=02c6138894335, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Acta Neuropathologica: 透明细胞脑膜瘤的定义是高度不同的DNA甲基化谱和SMARCE1突变, objectType=article, longId=205290, objectId=0680205290d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0680205290d6, replyNumber=0, likeNumber=77, createdTime=2021-01-05, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0680205290d6, moduleTitle=Acta Neuropathologica: 透明细胞脑膜瘤的定义是高度不同的DNA甲基化谱和SMARCE1突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0680205290d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388942, encodeId=19511388942cd, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=偏头痛的SMART管理, objectType=article, longId=204740, objectId=7a7b204e4021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a7b204e4021, replyNumber=0, likeNumber=51, createdTime=2020-12-23, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a7b204e4021, moduleTitle=偏头痛的SMART管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a7b204e4021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388941, encodeId=9b65138894152, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Eur Urol：锕-225-PSMA-617在镥-177-PSMA治疗失败后的晚期转移性去势抵抗性前列腺癌中的活性和不良反应 , objectType=article, longId=204687, objectId=679620468e97, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=679620468e97, replyNumber=0, likeNumber=63, createdTime=2020-12-21, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=679620468e97, moduleTitle=Eur Urol：锕-225-PSMA-617在镥-177-PSMA治疗失败后的晚期转移性去势抵抗性前列腺癌中的活性和不良反应 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=679620468e97)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388940, encodeId=268c138894051, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Br J Cancer：TNIK抑制剂NCB-0846阻断TGFβ/SMAD信号通路抑制肺癌的转移, objectType=article, longId=204320, objectId=7e9f20432020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e9f20432020, replyNumber=0, likeNumber=68, createdTime=2020-12-10, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e9f20432020, moduleTitle=Br J Cancer：TNIK抑制剂NCB-0846阻断TGFβ/SMAD信号通路抑制肺癌的转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e9f20432020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388939, encodeId=8b8013889393b, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=JNNP:诺西那生钠治疗脊髓性肌萎缩症(SMA)的儿童的运动单位变化, objectType=article, longId=203282, objectId=e358203282c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e358203282c7, replyNumber=0, likeNumber=69, createdTime=2020-11-13, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e358203282c7, moduleTitle=JNNP:诺西那生钠治疗脊髓性肌萎缩症(SMA)的儿童的运动单位变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e358203282c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388938, encodeId=0f00138893817, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=FDA批准口服性脊髓性肌萎缩症（SMA）药物Evrysdi, objectType=article, longId=199056, objectId=7cd91990560b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cd91990560b, replyNumber=0, likeNumber=66, createdTime=2020-08-11, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cd91990560b, moduleTitle=FDA批准口服性脊髓性肌萎缩症（SMA）药物Evrysdi, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cd91990560b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388937, encodeId=28d4138893e64, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Clini Cancer Res：SMARCA4突变可预测肺癌患者预后, objectType=article, longId=198071, objectId=4b131980e104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b131980e104, replyNumber=0, likeNumber=77, createdTime=2020-07-28, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b131980e104, moduleTitle=Clini Cancer Res：SMARCA4突变可预测肺癌患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b131980e104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1388936, encodeId=74be138893652, content=<a href='/topic/show?id=a75a1642585' target=_blank style='color:#2F92EE;'>#SMA#</a>, objectTitle=Small：FR+CTC检测攻克肺结节病理诊断的障碍, objectType=article, longId=196478, objectId=afd41964e8b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afd41964e8b2, replyNumber=0, likeNumber=61, createdTime=2020-06-27, rootId=0, userName=江川靖瑶, userId=e0752500025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afd41964e8b2, moduleTitle=Small：FR+CTC检测攻克肺结节病理诊断的障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=afd41964e8b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SMA

2020-05-29

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Br J Cancer：转移性去势抵抗性前列腺癌中雄激素受体基因扩增状态与177Lu-PSMA-617治疗抗性相关

2021-08-03

仁医06 (审核中...)

前往app查看评论内容

#SMA#

NEJM：177Lu-PSMA-617靶向放疗治疗PSMA阳性转移性去势抵抗性前列腺癌

2021-06-26

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

BJU Int：PSMA PET和MRI预测中度和高度风险前列腺癌患者的早期结果

2021-06-22

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

JAMA Neurol：Zolgensma治疗后5年，脊髓性肌肉萎缩症患者仍可获得长期临床缓解

2021-05-30

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Journal of Nuclear Medicine：美国单中心研究发现黑人前列腺癌68Ga-PSMA-11PET成像使用机会少

2021-05-14

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Cell Metab：肌酸通过激活Smad2/3促进肿瘤转移

2021-04-05

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Evrysdi治疗脊髓性肌萎缩症（SMA），CHMP持积极意见

2021-03-01

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Acta Neuropathologica: 具有SMARCA4突变的非典型畸胎样/横纹肌样肿瘤在分子水平上不同于SMARCB1缺陷病例

2021-02-20

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

定价为天价的SMA疗法卖得还好吗

2021-02-17

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Clin Cancer Res：PSMA靶向AMG160疗法在转移去势抵抗性前列腺癌临床前模型中具有强效的抗肿瘤活性

2021-02-08

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

ARTMS和Isotopia Molecular Imaging宣布成功通过QUANTM Irradiation System™和固态靶材，用经由回旋加速器生产的68Ga对PSMA-11进行多居里标记

2021-01-23

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒

2021-01-16

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Acta Neuropathologica: 透明细胞脑膜瘤的定义是高度不同的DNA甲基化谱和SMARCE1突变

2021-01-05

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

偏头痛的SMART管理

2020-12-23

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Eur Urol：锕-225-PSMA-617在镥-177-PSMA治疗失败后的晚期转移性去势抵抗性前列腺癌中的活性和不良反应

2020-12-21

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Br J Cancer：TNIK抑制剂NCB-0846阻断TGFβ/SMAD信号通路抑制肺癌的转移

2020-12-10

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

JNNP:诺西那生钠治疗脊髓性肌萎缩症(SMA)的儿童的运动单位变化

2020-11-13

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

FDA批准口服性脊髓性肌萎缩症（SMA）药物Evrysdi

2020-08-11

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Clini Cancer Res：SMARCA4突变可预测肺癌患者预后

2020-07-28

江川靖瑶 (审核中...)

前往app查看评论内容

#SMA#

Small：FR+CTC检测攻克肺结节病理诊断的障碍

2020-06-27

科室
- - 订阅+
  - 更多科室
工具
服务